Hepatic Encephalopathy and Liver Transplant: The Past, Present, and Future Towards Equitable Access

2021 ◽  
Author(s):  
Chathur Acharya ◽  
Jasmohan S Bajaj
Author(s):  
Masood Dehghani

Introduction: The only option for treatment of end stage liver diseases is liver transplantation. Afzalipour Hospital in Kerman, Iran is the third largest liver transplantation center in Iran. In this study, the outcomes of this center have been studied during the past 5 years. Methods: In this cross-sectional study, the pre and post transplantation’s clinical, demographic and outcome data of all patients who received liver transplant at Afzalipour Hospital during the past 5 years have been collected and reviewed. SPSS software ver. 16 was used to analyze the data. Results: Forty-three patients have received liver transplantation during this time interval. The 3-year survival rate of patients was 77%. The most common cause of death was primary nonfunction graft after transplantation. The most common complication was acute rejection (15%), all of which were successfully treated with corticosteroids. Conclusion:  Due to increment of cases of acute and chronic liver failure in the community and since the final treatment of these cases is liver transplantation, so there is need to develop liver transplant centers in the future. Quantitative and qualitative study of the activity of centers based liver transplant in Iran is necessary to set up successful centers.


2016 ◽  
Vol 22 (10) ◽  
pp. 1333-1342 ◽  
Author(s):  
Cristina Lucidi ◽  
Stefano Ginanni Corradini ◽  
Juan G. Abraldes ◽  
Manuela Merli ◽  
Puneeta Tandon ◽  
...  

2017 ◽  
Vol 112 ◽  
pp. S567
Author(s):  
Alex N. Zimmet ◽  
George Stukenborg ◽  
Blake Niccum ◽  
Gold Adkins ◽  
Jennifer Wang ◽  
...  

2009 ◽  
Vol 87 (5) ◽  
pp. 734-739 ◽  
Author(s):  
Marius Braun M ◽  
Nathan Bar-Nathan ◽  
Ezra Shaharabani ◽  
Sigal Aizner ◽  
Ran Tur-Kaspa ◽  
...  

2021 ◽  
Vol 15 ◽  
Author(s):  
Óscar López-Franco ◽  
Jean-Pascal Morin ◽  
Albertina Cortés-Sol ◽  
Tania Molina-Jiménez ◽  
Diana I. Del Moral ◽  
...  

Hepatic encephalopathy (HE) is one of the most disabling metabolic diseases. It consists of a complication of liver disease through the action of neurotoxins, such as excessive production of ammonia from liver, resulting in impaired brain function. Its prevalence and incidence are not well known, although it has been established that up to 40% of cirrhotic patients may develop HE. Patients with HE episodes display a wide range of neurological disturbances, from subclinical alterations to coma. Recent evidence suggests that the resolution of hepatic encephalopathy does not fully restore cognitive functioning in cirrhotic patients. Therefore, the aim of this review was to evaluate the evidence supporting the presence of lingering cognitive deficits in patients with a history of HE compared to patients without HE history and how liver transplant affects such outcome in these patients. We performed two distinct meta-analysis of continuous outcomes. In both cases the results were pooled using random-effects models. Our results indicate that cirrhotic patients with a history of HE show clear cognitive deficits compared control cirrhotic patients (Std. Mean Difference (in SDs) = −0.72 [CI 95%: −0.94, −0.50]) and that these differences are not fully restored after liver transplant (Std. Mean Difference (in SDs) = −0.72 [CI 95%: −0.94, −0.50]).


1996 ◽  
Vol 62 (6) ◽  
pp. 764-767 ◽  
Author(s):  
Maria L. Zeneroli ◽  
Ivo Venturini ◽  
Rossella Avallone ◽  
Franco Farina ◽  
Lorenzo Corsi ◽  
...  

2017 ◽  
Vol 118 (2) ◽  
pp. 251-258 ◽  
Author(s):  
Ruo-Mi Guo ◽  
Qing-Ling Li ◽  
Li-Ru Zhong ◽  
Yu Guo ◽  
Ju Jiao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document